Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomized Controlled Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission

NCT01603251 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT01603251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01603251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomized Controlled Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2013
Completion date
April 30, 2013
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria